{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:08:36Z","timestamp":1773868116028,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T00:00:00Z","timestamp":1518998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T00:00:00Z","timestamp":1518998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001592","name":"Higher Education Authority","doi-asserted-by":"publisher","award":["PRTLI cycle 5"],"award-info":[{"award-number":["PRTLI cycle 5"]}],"id":[{"id":"10.13039\/501100001592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s10637-017-0543-z","type":"journal-article","created":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T07:57:03Z","timestamp":1519027023000},"page":"523-535","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Involvement of NF-\u03baB in mediating the anti-tumour effects of combretastatins in T cells"],"prefix":"10.1007","volume":"36","author":[{"given":"Jade K.","family":"Pollock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema M.","family":"Nathwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Kinsella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niamh M.","family":"O\u2019Boyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary J.","family":"Meegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela M.","family":"Zisterer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,19]]},"reference":[{"issue":"8","key":"543_CR1","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.2217\/fon.10.90","volume":"6","author":"G Nagaiah","year":"2010","unstructured":"Nagaiah G, Remick SC (2010) Combretastatin A4 phosphate: a novel vascular disrupting agent. Future Oncol 6(8):1219\u20131228","journal-title":"Future Oncol"},{"issue":"2","key":"543_CR2","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3892\/or.2012.2181","volume":"29","author":"SM Nathwani","year":"2013","unstructured":"Nathwani SM et al (2013) Novel cis-restricted beta-lactam combretastatin A-4 analogues display anti-vascular and anti-metastatic properties in vitro. Oncol Rep 29(2):585\u2013594","journal-title":"Oncol Rep"},{"issue":"2","key":"543_CR3","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1124\/jpet.110.170415","volume":"335","author":"LM Greene","year":"2010","unstructured":"Greene LM et al (2010) The vascular targeting agent Combretastatin-A4 and a novel cis-restricted \u03b2-lactam analogue, CA-432, induce apoptosis in human chronic myeloid leukemia cells and ex vivo patient samples including those displaying multidrug resistance. J Pharmacol Exp Ther 335(2):302\u2013313","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"543_CR4","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.bcp.2012.06.005","volume":"84","author":"LM Greene","year":"2012","unstructured":"Greene LM et al (2012) The vascular targeting agent Combretastatin-A4 directly induces autophagy in adenocarcinoma-derived colon cancer cells. Biochem Pharmacol 84(5):612\u2013624","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"543_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1101\/gad.255877.114","volume":"29","author":"Y Pang","year":"2015","unstructured":"Pang Y et al (2015) Structure of the apoptosome: mechanistic insights into activation of an initiator caspase from drosophila. Genes Dev 29(3):277\u2013287","journal-title":"Genes Dev"},{"issue":"5","key":"543_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674","journal-title":"Cell"},{"issue":"7092","key":"543_CR7","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature04870","volume":"441","author":"M Karin","year":"2006","unstructured":"Karin M (2006) Nuclear factor-kappaB in cancer development and progression. Nature 441(7092):431\u2013436","journal-title":"Nature"},{"issue":"4","key":"543_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1074-7613(00)80252-6","volume":"4","author":"H Hsu","year":"1996","unstructured":"Hsu H et al (1996) TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4(4):387\u2013396","journal-title":"Immunity"},{"issue":"7007","key":"543_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature02924","volume":"431","author":"E Pikarsky","year":"2004","unstructured":"Pikarsky E et al (2004) NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431(7007):461\u2013466","journal-title":"Nature"},{"issue":"6","key":"543_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1158\/2159-8290.CD-11-0260","volume":"1","author":"BB Aggarwal","year":"2011","unstructured":"Aggarwal BB, Sung B (2011) NF-kappaB in cancer: a matter of life and death. Cancer Discov 1(6):469\u2013471","journal-title":"Cancer Discov"},{"issue":"12","key":"543_CR11","doi-asserted-by":"publisher","first-page":"5752","DOI":"10.1016\/j.ejmech.2010.09.033","volume":"45","author":"M Carr","year":"2010","unstructured":"Carr M et al (2010) Lead identification of conformationally restricted \u03b2-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects. Eur J Med Chem 45(12):5752\u20135766","journal-title":"Eur J Med Chem"},{"key":"543_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"TC Chou","year":"1984","unstructured":"Chou TC, Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzym Regul 22:27\u201355","journal-title":"Adv Enzym Regul"},{"issue":"6","key":"543_CR13","first-page":"1345","volume":"63","author":"W Lu","year":"2003","unstructured":"Lu W et al (2003) Active specific immunotherapy against occult brain metastasis. Cancer Res 63(6):1345\u20131350","journal-title":"Cancer Res"},{"issue":"6","key":"543_CR14","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/pros.22599","volume":"73","author":"Y Nakamura","year":"2013","unstructured":"Nakamura Y et al (2013) Cyclin D1 (CCND1) expression is involved in estrogen receptor beta (ERbeta) in human prostate cancer. Prostate 73(6):590\u2013595","journal-title":"Prostate"},{"issue":"1","key":"543_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","volume":"165","author":"W Hugo","year":"2016","unstructured":"Hugo W et al (2016) Genomic and Transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma. Cell 165(1):35\u201344","journal-title":"Cell"},{"issue":"1","key":"543_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bbrc.2013.08.042","volume":"439","author":"H Pham","year":"2013","unstructured":"Pham H et al (2013) miR-143 decreases COX-2 mRNA stability and expression in pancreatic cancer cells. Biochem Biophys Res Commun 439(1):6\u201311","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"543_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12935-015-0260-7","volume":"15","author":"B Liu","year":"2015","unstructured":"Liu B, Qu L, Yan S (2015) Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity. Cancer Cell Int 15(1):106","journal-title":"Cancer Cell Int"},{"issue":"242","key":"543_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1126\/scitranslmed.3008455","volume":"6","author":"L Xu","year":"2014","unstructured":"Xu L, et al. (2014) COX-2 Inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models. Sci Transl Med 6(242):242","journal-title":"Sci Transl Med"},{"issue":"8","key":"543_CR19","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1158\/0008-5472.CAN-09-4230","volume":"70","author":"B Sung","year":"2010","unstructured":"Sung B, Ahn KS, Aggarwal BB (2010) Noscapine, a Benzylisoquinoline alkaloid, sensitizes leukemic cells to chemotherapeutic agents and cytokines by modulating the NF-kappa B signaling pathway. Cancer Res 70(8):3259\u20133268","journal-title":"Cancer Res"},{"issue":"4","key":"543_CR20","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.bcp.2013.12.017","volume":"87","author":"JC Lennon","year":"2014","unstructured":"Lennon JC et al (2014) The novel pyrrolo-1,5-benzoxazepine, PBOX-6, synergistically enhances the apoptotic effects of carboplatin in drug sensitive and multidrug resistant neuroblastoma cells. Biochem Pharmacol 87(4):611\u2013624","journal-title":"Biochem Pharmacol"},{"issue":"15","key":"543_CR21","doi-asserted-by":"publisher","first-page":"15196","DOI":"10.1074\/jbc.M310947200","volume":"279","author":"X Ling","year":"2004","unstructured":"Ling X et al (2004) Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G(2)\/M arrest. J Biol Chem 279(15):15196\u201315203","journal-title":"J Biol Chem"},{"issue":"7","key":"543_CR22","first-page":"4239","volume":"7","author":"W Zeng","year":"2014","unstructured":"Zeng W et al (2014) Bortezomib-based chemotherapy regimens can improve response in newly diagnosed multiple myeloma patients with bcl-2 and survivin overexpression. Int J Clin Exp Pathol 7(7):4239\u20134246","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"543_CR23","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1038\/leu.2014.96","volume":"28","author":"N Purroy","year":"2014","unstructured":"Purroy N et al (2014) Targeting the proliferative and chemoresistant compartment in chronic lymphocytic leukemia by inhibiting survivin protein. Leukemia 28(10):1993\u20132004","journal-title":"Leukemia"},{"issue":"2","key":"543_CR24","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.bmc.2013.12.015","volume":"22","author":"DV Demchuk","year":"2014","unstructured":"Demchuk DV et al (2014) Synthesis and antiproliferative activity of conformationally restricted 1,2,3-triazole analogues of combretastatins in the sea urchin embryo model and against human cancer cell lines. Bioorg Med Chem 22(2):738\u2013755","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"543_CR25","first-page":"528","volume":"63","author":"D Xu","year":"2008","unstructured":"Xu D et al (2008) Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells. Pharmazie 63(7):528\u2013533","journal-title":"Pharmazie"},{"issue":"1","key":"543_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1158\/1535-7163.MCT-13-0153","volume":"13","author":"D Finlay","year":"2014","unstructured":"Finlay D et al (2014) Small-molecule IAP antagonists sensitize cancer cells to TRAIL-induced apoptosis: roles of XIAP and cIAPs. Mol Cancer Ther 13(1):5\u201315","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"543_CR27","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1128\/MCB.26.2.699-708.2006","volume":"26","author":"D Conte","year":"2006","unstructured":"Conte D et al (2006) Inhibitor of apoptosis protein cIAP2 is essential for lipopolysaccharide-induced macrophage survival. Mol Cell Biol 26(2):699\u2013708","journal-title":"Mol Cell Biol"},{"issue":"6A","key":"543_CR28","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1111\/j.1582-4934.2009.00918.x","volume":"14","author":"B Janji","year":"2010","unstructured":"Janji B et al (2010) The actin filament cross-linker L-plastin confers resistance to TNF-alpha in MCF-7 breast cancer cells in a phosphorylation-dependent manner. J Cell Mol Med 14(6A):1264\u20131275","journal-title":"J Cell Mol Med"},{"issue":"2","key":"543_CR29","first-page":"229","volume":"3","author":"Y Mizutani","year":"1993","unstructured":"Mizutani Y, Bonavida B (1993) Overcoming tnf-alpha and cddp resistance of a human ovarian-cancer cell-line (c30) by treatment with buthionine sulfoximine in combination with tnf-alpha and or cddp. Int J Oncol 3(2):229\u2013235","journal-title":"Int J Oncol"},{"key":"543_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1476-4598-10-106","volume":"10","author":"U Bharadwaj","year":"2011","unstructured":"Bharadwaj U et al (2011) Mesothelin confers pancreatic cancer cell resistance to TNF-alpha-induced apoptosis through Akt\/PI3K\/NF-kappaB activation and IL-6\/Mcl-1 overexpression. Mol Cancer 10:106","journal-title":"Mol Cancer"},{"issue":"12","key":"543_CR31","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s00384-012-1493-8","volume":"27","author":"P Ferroni","year":"2012","unstructured":"Ferroni P et al (2012) Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer. Int J Color Dis 27(12):1561\u20131567","journal-title":"Int J Color Dis"},{"issue":"6","key":"543_CR32","first-page":"12","volume":"1","author":"T Tian","year":"2014","unstructured":"Tian T, Wang M, Ma D (2014) TNF-\u03b1, a good or bad factor in hematological diseases? Stem Cell Investig 1(6):12","journal-title":"Stem Cell Investig"},{"issue":"22","key":"543_CR33","doi-asserted-by":"publisher","first-page":"14008","DOI":"10.1074\/jbc.273.22.14008","volume":"273","author":"DK Giri","year":"1998","unstructured":"Giri DK, Aggarwal BB (1998) Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates. J Biol Chem 273(22):14008\u201314014","journal-title":"J Biol Chem"},{"issue":"6","key":"543_CR34","doi-asserted-by":"publisher","first-page":"e40355","DOI":"10.1371\/journal.pone.0040355","volume":"7","author":"HR Jin","year":"2012","unstructured":"Jin HR et al (2012) Cryptopleurine targets NF-kappaB pathway, leading to inhibition of gene products associated with cell survival, proliferation, invasion, and angiogenesis. PLoS One 7(6):e40355","journal-title":"PLoS One"},{"issue":"10","key":"543_CR35","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1182\/blood-2007-03-079616","volume":"110","author":"MK Pandey","year":"2007","unstructured":"Pandey MK et al (2007) Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappa B signaling pathway. Blood 110(10):3517\u20133525","journal-title":"Blood"},{"issue":"7","key":"543_CR36","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1158\/1535-7163.MCT-05-0067","volume":"4","author":"K Hara","year":"2005","unstructured":"Hara K et al (2005) Synergistic enhancement of TRAIL- and tumor necrosis factor alpha-induced cell death by a phenoxazine derivative. Mol Cancer Ther 4(7):1121\u20131127","journal-title":"Mol Cancer Ther"},{"issue":"5288","key":"543_CR37","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1126\/science.274.5288.787","volume":"274","author":"DJ Van Antwerp","year":"1996","unstructured":"Van Antwerp DJ et al (1996) Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274(5288):787\u2013789","journal-title":"Science"},{"key":"543_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1475-2867-10-43","volume":"10","author":"CH Cheung","year":"2010","unstructured":"Cheung CH et al (2010) Correction: a cell-permeable dominant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-alpha therapy. Cancer Cell Int 10:43","journal-title":"Cancer Cell Int"},{"issue":"39","key":"543_CR39","doi-asserted-by":"publisher","first-page":"8021","DOI":"10.1038\/sj.onc.1206837","volume":"22","author":"G Totzke","year":"2003","unstructured":"Totzke G, Schulze-Osthoff K, Janicke RU (2003) Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition. Oncogene 22(39):8021\u20138030","journal-title":"Oncogene"},{"issue":"6","key":"543_CR40","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s13402-015-0243-7","volume":"38","author":"K Mahal","year":"2015","unstructured":"Mahal K et al (2015) Role of JNK and NF-kappaB in mediating the effect of combretastatin A-4 and brimamin on endothelial and carcinoma cells. Cell Oncol (Dordr) 38(6):463\u2013478","journal-title":"Cell Oncol (Dordr)"},{"issue":"2","key":"543_CR41","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/j.1471-4159.2006.04005.x","volume":"99","author":"GG Mackenzie","year":"2006","unstructured":"Mackenzie GG, Keen CL, Oteiza PI (2006) Microtubules are required for NF-kappaB nuclear translocation in neuroblastoma IMR-32 cells: modulation by zinc. J Neurochem 99(2):402\u2013415","journal-title":"J Neurochem"},{"issue":"14","key":"543_CR42","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1096\/fj.03-0329fje","volume":"17","author":"YJ Jung","year":"2003","unstructured":"Jung YJ et al (2003) IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB\/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 17(14):2115\u20132117","journal-title":"FASEB J"},{"issue":"10","key":"543_CR43","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s00018-004-3408-5","volume":"61","author":"I Cvetkovic","year":"2004","unstructured":"Cvetkovic I et al (2004) Taxol activates inducible nitric oxide synthase in rat astrocytes: the role of MAP kinases and NF-kappaB. Cell Mol Life Sci 61(10):1167\u20131175","journal-title":"Cell Mol Life Sci"},{"issue":"19","key":"543_CR44","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1016\/j.yexcr.2009.08.020","volume":"315","author":"RW Jackman","year":"2009","unstructured":"Jackman RW et al (2009) Microtubule-mediated NF-kappaB activation in the TNF-alpha signaling pathway. Exp Cell Res 315(19):3242\u20133249","journal-title":"Exp Cell Res"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-017-0543-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-017-0543-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-017-0543-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:22:53Z","timestamp":1678558973000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-017-0543-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,19]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["543"],"URL":"https:\/\/doi.org\/10.1007\/s10637-017-0543-z","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,19]]},"assertion":[{"value":"3 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Jade K. Pollock declares that she has no conflict of interest. Lisa M. Greene declares that she has no conflict of interest. Seema M. Nathwani declares that she has no conflict of interest. Niamh M. O\u2019Boyle declares that she has no conflict of interest. Paula Kinsella declares that she has no conflict of interest. Mary J. Meegan declares that she has no conflict of interest. Daniela M. Zisterer declares that she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}